Ownership

Carmen Chang

Insider Reports History

Entity: Individual
Location: 2855 Sand Hill Road, Menlo Park, CA
Signature: /s/ Zachary Bambach, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carmen Chang:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Monte Rosa Therapeutics, Inc.	10%+ Owner	Common Stock	7.69M	$146M	$19.00	Jun 28, 2021	Indirect
Savara Inc	10%+ Owner	Common Stock	24.5M	$109M	$4.45	Jul 17, 2023	Indirect
Korro Bio, Inc.	10%+ Owner	Common Stock	1.09M	$61.1M	$56.00	Apr 22, 2024	Indirect
MBX Biosciences, Inc.	10%+ Owner	Common Stock	3.61M	$38.6M	$10.69	Sep 16, 2024	Indirect
Coursera, Inc.	Director	Common Stock	2.21M	$17.9M	$8.10	May 22, 2024	Indirect
Trevi Therapeutics, Inc.	10%+ Owner	Common Stock	949K	$1.92M	$2.02	Apr 11, 2022	Indirect
Metacrine, Inc.	10%+ Owner	Common Stock	2.56M	$1.2M	$0.47	Dec 22, 2021	Indirect
Coursera, Inc.	Director	Common Stock	66.5K	$539K	$8.10	May 22, 2024	Direct
Mirum Pharmaceuticals, Inc.	10%+ Owner	Common Stock	135	$3.78K	$28.04	Jun 13, 2023	Direct
Trevi Therapeutics, Inc.	10%+ Owner	Pre-Funded Warrants	3M			Apr 11, 2022	Indirect
NeueHealth, Inc.	10%+ Owner	Warrant (Right to Buy)	557K			Oct 1, 2024	Indirect
Akouos, Inc.	10%+ Owner	Common Stock	0		$12.50	Nov 30, 2022	Indirect
GENOCEA BIOSCIENCES, INC.	10%+ Owner	Common Stock	0		$1.25	May 25, 2022	Indirect
MBX Biosciences, Inc.	10%+ Owner	Series A Convertible Preferred Stock	0			Sep 16, 2024	Indirect
MBX Biosciences, Inc.	10%+ Owner	Series B Convertible Preferred Stock	0			Sep 16, 2024	Indirect
Mirum Pharmaceuticals, Inc.	10%+ Owner	Common Stock	0		$28.04	Jun 13, 2023	Indirect
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series A-2 convertible preferred stock	0			Jun 28, 2021	Indirect
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series B convertible preferred stock	0		$2.00	Jun 28, 2021	Indirect
Monte Rosa Therapeutics, Inc.	10%+ Owner	Series C convertible preferred Stock	0			Jun 28, 2021	Indirect

Previous1Next

Showing 1 to 19 of 19 entries

Insider Reports Filed by Carmen Chang

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
NEUE	NeueHealth, Inc.	Oct 1, 2024	3	$0	4	Oct 3, 2024	10%+ Owner
MBX	MBX Biosciences, Inc.	Sep 16, 2024	5	$8M	4	Sep 17, 2024	10%+ Owner
MBX	MBX Biosciences, Inc.	Sep 12, 2024	0	$0	3	Sep 12, 2024	10%+ Owner
COUR	Coursera, Inc.	May 22, 2024	1	$0	4	May 24, 2024	Director
KRRO	Korro Bio, Inc.	Apr 22, 2024	1	$1M	4	Apr 24, 2024	10%+ Owner
NEUE	NeueHealth, Inc.	Apr 8, 2024	3	$0	4	Apr 10, 2024	10%+ Owner
BHG	Bright Health Group Inc.	Dec 19, 2023	1	$0	4	Dec 21, 2023	10%+ Owner
FREQ	Korro Bio, Inc.	Nov 3, 2023	0	$0	3	Nov 7, 2023	10%+ Owner
BHG	Bright Health Group Inc.	Oct 31, 2023	1	$0	4	Nov 2, 2023	10%+ Owner
BHG	Bright Health Group Inc.	Sep 15, 2023	1	$0	4	Sep 19, 2023	10%+ Owner
BHG	Bright Health Group Inc.	Aug 11, 2023	1	$0	4	Aug 15, 2023	10%+ Owner
SVRA	Savara Inc	Jul 17, 2023	1	$1M	4	Jul 19, 2023	10%+ Owner
MIRM	Mirum Pharmaceuticals, Inc.	Jun 13, 2023	4	$0	4	Jun 15, 2023	10%+ Owner
COUR	Coursera, Inc.	May 24, 2023	1	$0	4	May 26, 2023	Director
COUR	Coursera, Inc.	Mar 15, 2023	1	-$14.5K	4	Mar 17, 2023	Director
COUR	Coursera, Inc.	Feb 15, 2023	1	$0	4	Feb 17, 2023	Director
AKUS	Akouos, Inc.	Nov 30, 2022	1	$0	4	Dec 2, 2022	10%+ Owner
BHG	Bright Health Group Inc.	Oct 17, 2022	2	$138M	4	Oct 19, 2022	10%+ Owner
GNCA	GENOCEA BIOSCIENCES, INC.	May 24, 2022	2	-$751K	4	May 26, 2022	10%+ Owner
COUR	Coursera, Inc.	May 13, 2022	1	$0	4	May 16, 2022	Director
TRVI	Trevi Therapeutics, Inc.	Apr 11, 2022	3	$12.5M	4	Apr 13, 2022	10%+ Owner
BHG	Bright Health Group Inc.	Jan 3, 2022	2	$200M	4	Jan 5, 2022	10%+ Owner
MTCR	Metacrine, Inc.	Dec 10, 2021	3	-$494K	4	Dec 27, 2021	10%+ Owner
COUR	Coursera, Inc.	Nov 1, 2021	1	$0	4	Nov 3, 2021	Director
TRVI	Trevi Therapeutics, Inc.	Oct 18, 2021	3	$0	4	Oct 19, 2021	10%+ Owner
COUR	Coursera, Inc.	Oct 12, 2021	0	$0	3	Oct 12, 2021	Director
BHG	Bright Health Group Inc.	Jun 28, 2021	12	$35M	4	Jun 30, 2021	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 28, 2021	7	$20M	4	Jun 30, 2021	10%+ Owner
BHG	Bright Health Group Inc.	Jun 24, 2021	0	$0	3	Jun 24, 2021	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 23, 2021	0	$0	3	Jun 23, 2021	10%+ Owner